MedPath

ORFADIN 4 mg/ml SUSPENSION ORAL

ORFADIN 4 mg/ml SUSPENSION ORAL

Commercialized
Register Number

104303005

Prescription Type

Uso Hospitalario

Authorization Date

Jul 26, 2015

Dosage Form

SUSPENSIÓN ORAL

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number104303005
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

NITISINONAActive
Quantity: 4,0 mg
Name: NITISINONA

ATC CLASSIFICATION (3)

A16A
A16AX
A16AX04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.